PharmEco Group of Companies

Search

RU | EN

BioJet – EN
  • About
    • General information
    • Administration
    • Pharmacovigilance
    • Business ethics
  • Production
  • Our products
  • News
  • Contacts

Wildberries launches sales of over-the-counter medicines in Russia

Online retailer Wildberries will allow the sale of over-the-counter drugs on the platform throughout the country. Previously, this opportunity was only available to residents of Moscow and the Moscow region – these regions were pilot and tested the initiative since 2021.

This only applies to those medications that can be purchased without a doctor’s prescription. Such products can only be sold if you have a license for the retail sale of drugs, as well as after the platform has verified such documents.

The storage, assembly and delivery of goods in this category will be carried out by the sellers themselves. “In this case, the platform directly connects the seller with the buyer,” the company explained. Earlier, at the beginning of 2023, Wildberries banned the sale of dietary supplements without confirmation of the authenticity of the state registration certificate.

Source: GxP-news.

Current news

  • March 31, 2025

    Russian spending on antidepressants reached nearly 3 billion rubles since the beginning of the year

    Pharmacy chains earned 2.8 billion rubles from antidepressant sales in January-February 2025. A total of…

  • March 31, 2025

    The State Duma rejected the bill on accelerated market entry for generics

    On March 20, deputies of the State Duma rejected in the first reading a bill…

  • March 31, 2025

    Russia to increase production of infliximab-based medicines

    The company “Pharmapark” plans to steadily increase its production volumes. Specifically, over 30,000 packages of…

  • March 31, 2025

    A unified database for veterinary drugs will be launched in EAEU countries

    The Collegium of the Eurasian Economic Commission (EEC) has approved the creation of a unified…

  • March 31, 2025

    MSD will pay up to $2 billion for Chinese heart medication

    One of the world’s largest pharmaceutical companies, MSD, will pay up to $2 billion for…

LLC “BioJet”. all rights reserved

  • Legal information